Matthias Alder, Chief Executive Officer at Gain Therapeutics, Inc. (GANX), sold 206 shares at $2.46 ($507) on 2023-12-21, disclosed to the SEC on 2023-12-22.
Open-market sale of $507 GANX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MITI | SELL | 2010-01-27 | $83K | — | Filing → |
| MITI | SELL | 2010-01-21 | $72K | — | Filing → |